STOCK TITAN

Accelevation Launches Roadshow for Proposed Initial Public Offering

If completed, the ACCV IPO would fund debt repayment and corporate uses while also listing the company on Nasdaq Global Select Market.

(Neutral)
(Neutral)
Tags

Accelevation Holdings (ACCV) has launched a roadshow for a proposed initial public offering of 30,000,000 shares of its Class A common stock.

The deal includes 8,635,165 primary shares from Accelevation and 21,364,835 secondary shares from selling stockholders, plus a 30‑day option for underwriters to buy up to 4,500,000 additional shares. The expected IPO price range is $20.00–$24.00 per share. Accelevation has applied to list on the Nasdaq Global Select Market under the ticker “ACCV.” Net primary proceeds are intended to purchase units in Accelevation Holdings LLC, which plans to use the funds to repay debt, cover offering and organizational costs, and for general corporate purposes.

Loading...
Loading translation...

Positive

  • Proposed IPO of 30,000,000 Class A shares with a $20–$24 price range
  • Application to list on Nasdaq Global Select Market under ticker ACCV
  • Primary proceeds from 8,635,165 shares earmarked for debt repayment and corporate purposes
  • Underwriters granted a 30‑day option for up to 4,500,000 additional shares

Negative

  • Accelevation will not receive proceeds from 21,364,835 secondary shares sold by existing stockholders

News Explained

The proposed IPO remains pending: although the roadshow has begun and the registration statement has been filed, it is not effective, so the disclosed shares cannot yet be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MIAMISBURG, Ohio, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Accelevation Holdings Corp. (“Accelevation”) today announced the launch of the roadshow for its proposed initial public offering of 30,000,000 shares of its Class A common stock, including 8,635,165 shares offered by Accelevation and 21,364,835 shares offered by certain selling stockholders. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 4,500,000 shares of Class A common stock. The initial public offering price is currently expected to be between $20.00 and $24.00 per share. Accelevation has applied to list its shares on The Nasdaq Global Select Market under the ticker symbol “ACCV.”

Accelevation intends to use the net proceeds from the offering to purchase newly issued units in Accelevation Holdings LLC. In turn, Accelevation Holdings LLC intends to apply the balance of the net proceeds it receives from Accelevation to repay indebtedness, pay expenses incurred in connection with the offering and certain organizational transactions and for general corporate purposes. Accelevation will not receive any of the proceeds from the sale of shares of Class A common stock by the selling stockholders.

Morgan Stanley and J.P. Morgan are acting as joint lead bookrunning managers for the proposed offering. Goldman Sachs & Co. LLC, Barclays and BofA Securities are acting as joint bookrunning managers. Houlihan Lokey, Baird, William Blair, Piper Sandler and Wolfe | Nomura Alliance are acting as additional bookrunners. A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission (“SEC”) but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the preliminary prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at prospectus-eq_fi@jpmchase.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Accelevation

Accelevation is a leading designer, manufacturer and installer of customized structural, electrical and mechanical systems for mission-critical infrastructure. Its vertically integrated model combines U.S.-based manufacturing and nationwide field service capabilities to move customers faster from design through deployment with innovative, factory-built solutions engineered for speed, scalability and certainty. Accelevation solves complex needs at scale while investing in its communities, growing the skilled trades and creating opportunities for people to build lasting careers and share in the value they create. Accelevation’s principal executive offices are located at 9555 N. Springboro Pike, Suite 400, Miamisburg, Ohio 45342, and its telephone number is (937) 258-0616.



For further information:

Investor Relations Contact:
Larry De Maria
ir@accelevation.com
+1 (937) 560-1133

Media Contact:
Chandler Martin
media@accelevation.com
+1 (937) 802-2931

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How are the 30,000,000 IPO shares of Accelevation divided between the company and selling stockholders?

The offering comprises 8,635,165 shares of Class A common stock offered by Accelevation and 21,364,835 shares offered by certain selling stockholders.

What over-allotment option is being granted to the underwriters in Accelevation's proposed IPO?

Selling stockholders intend to grant the underwriters a 30‑day option to purchase up to an additional 4,500,000 shares of Class A common stock.

How does Accelevation plan to use the net proceeds it receives from the IPO?

Accelevation intends to use its net proceeds to purchase newly issued units in Accelevation Holdings LLC. Accelevation Holdings LLC plans to apply the balance of the net proceeds it receives to repay indebtedness, pay expenses related to the offering and certain organizational transactions, and for general corporate purposes.

What is the current regulatory status of Accelevation's IPO registration statement?

A registration statement for the securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. The securities may not be sold, nor may offers to buy be accepted, before the registration statement becomes effective.

How can investors obtain the preliminary prospectus for Accelevation's proposed IPO?

The preliminary prospectus can be obtained for free by visiting the SEC's EDGAR site at www.sec.gov. Alternatively, copies may be requested from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014, or from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at prospectus-eq_fi@jpmchase.com.

Who are the underwriters involved in Accelevation's proposed IPO?

Morgan Stanley and J.P. Morgan are joint lead bookrunning managers. Goldman Sachs & Co. LLC, Barclays and BofA Securities are joint bookrunning managers, and Houlihan Lokey, Baird, William Blair, Piper Sandler and Wolfe | Nomura Alliance are additional bookrunners.

Keep reading